{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:08:34Z","timestamp":1793981314578,"version":"4.8.0"},"reference-count":218,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03673-6","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T15:59:46Z","timestamp":1740239986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Inflammation, microbiota, and pancreatic cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"XiaoLiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feixia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Reza","family":"Aref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Ashrafizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"issue":"12","key":"3673_CR1","first-page":"6176","volume":"13","author":"R Sturgeon","year":"2023","unstructured":"Sturgeon R, Goel P, Singh RK. Tumor-associated neutrophils in pancreatic cancer progression and metastasis. Am J Cancer Res. 2023;13(12):6176.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"3673_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"3673_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.695627","volume":"11","author":"A Pappalardo","year":"2021","unstructured":"Pappalardo A, et al. Adjuvant treatment in pancreatic cancer: shaping the future of the curative setting. Front Oncol. 2021;11: 695627.","journal-title":"Front Oncol"},{"issue":"11","key":"3673_CR4","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1001\/jamaoncol.2020.3537","volume":"6","author":"S van Roessel","year":"2020","unstructured":"van Roessel S, et al. Evaluation of adjuvant chemotherapy in patients with resected pancreatic cancer after neoadjuvant FOLFIRINOX treatment. JAMA Oncol. 2020;6(11):1733\u201340.","journal-title":"JAMA Oncol"},{"issue":"17","key":"3673_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMra0901557","volume":"362","author":"M Hidalgo","year":"2010","unstructured":"Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362(17):1605\u201317.","journal-title":"N Engl J Med"},{"issue":"3","key":"3673_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0002-9610(03)00226-5","volume":"186","author":"SM Cowgill","year":"2003","unstructured":"Cowgill SM, Muscarella P. The genetics of pancreatic cancer. Am J Surg. 2003;186(3):279\u201386.","journal-title":"Am J Surg"},{"issue":"11","key":"3673_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41419-021-04258-7","volume":"12","author":"CH Chang","year":"2021","unstructured":"Chang CH, Pauklin S. Extracellular vesicles in pancreatic cancer progression and therapies. Cell Death Dis. 2021;12(11):973.","journal-title":"Cell Death Dis"},{"issue":"17","key":"3673_CR8","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1200\/JCO.2008.16.6702","volume":"26","author":"CJ Lee","year":"2008","unstructured":"Lee CJ, Dosch J, Simeone DM. Pancreatic cancer stem cells. J Clin Oncol. 2008;26(17):2806\u201312.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3673_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/bjc.2014.215","volume":"111","author":"S Eser","year":"2014","unstructured":"Eser S, et al. Oncogenic KRAS signalling in pancreatic cancer. Br J Cancer. 2014;111(5):817\u201322.","journal-title":"Br J Cancer"},{"issue":"4","key":"3673_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1101\/gad.275776.115","volume":"30","author":"H Ying","year":"2016","unstructured":"Ying H, et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2016;30(4):355\u201385.","journal-title":"Genes Dev"},{"issue":"24","key":"3673_CR11","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1158\/0008-5472.CAN-23-0464","volume":"83","author":"Y Cui","year":"2023","unstructured":"Cui Y, et al. Fructose-induced mTORC1 activation promotes pancreatic cancer progression through inhibition of autophagy. Cancer Res. 2023;83(24):4063\u201379.","journal-title":"Cancer Res"},{"issue":"10","key":"3673_CR12","first-page":"4222","volume":"61","author":"V Ellenrieder","year":"2001","unstructured":"Ellenrieder V, et al. Transforming growth factor \u03b21 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Can Res. 2001;61(10):4222\u20138.","journal-title":"Can Res"},{"issue":"17","key":"3673_CR13","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.3390\/ijms20174242","volume":"20","author":"M Ram Makena","year":"2019","unstructured":"Ram Makena M, et al. Wnt\/\u03b2-catenin signaling: the culprit in pancreatic carcinogenesis and therapeutic resistance. Int J Mol Sci. 2019;20(17):4242.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"3673_CR14","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.2174\/13816128112092464","volume":"18","author":"J Cui","year":"2012","unstructured":"Cui J, et al. Role of Wnt\/\u03b2-catenin signaling in drug resistance of pancreatic cancer. Curr Pharm Des. 2012;18(17):2464\u201371.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"3673_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","volume":"19","author":"M Lesina","year":"2011","unstructured":"Lesina M, et al. Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell. 2011;19(4):456\u201369.","journal-title":"Cancer Cell"},{"issue":"40","key":"3673_CR16","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1038\/onc.2009.220","volume":"28","author":"JM Bailey","year":"2009","unstructured":"Bailey JM, Mohr AM, Hollingsworth MA. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene. 2009;28(40):3513\u201325.","journal-title":"Oncogene"},{"issue":"1","key":"3673_CR17","doi-asserted-by":"publisher","first-page":"8444","DOI":"10.1038\/s41467-023-44126-w","volume":"14","author":"M Maurin","year":"2023","unstructured":"Maurin M, et al. RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing. Nat Commun. 2023;14(1):8444.","journal-title":"Nat Commun"},{"issue":"2","key":"3673_CR18","doi-asserted-by":"publisher","first-page":"e1370","DOI":"10.1002\/wsbm.1370","volume":"9","author":"LL Munn","year":"2017","unstructured":"Munn LL. Cancer and inflammation. Wiley Interdiscip Rev Syst Biol Med. 2017;9(2):e1370.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"4","key":"3673_CR19","doi-asserted-by":"publisher","first-page":"G318","DOI":"10.1152\/ajpgi.00119.2023","volume":"325","author":"SJ McDonald","year":"2023","unstructured":"McDonald SJ, et al. Panaxynol alleviates colorectal cancer in a murine model via suppressing macrophages and inflammation. Am J Physiol Gastrointest Liver Physiol. 2023;325(4):G318-g333.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3673_CR20","first-page":"450","volume":"3","author":"Y Tang","year":"2023","unstructured":"Tang Y, et al. MZB1-mediated IgA secretion suppresses the development and progression of colorectal cancer triggered by gut inflammation. Mucosal Immunol. 2023;3:450.","journal-title":"Mucosal Immunol"},{"issue":"5","key":"3673_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M. NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309\u201324.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"3673_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5(10):749\u201359.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"3673_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000109","volume":"2","author":"LM Staudt","year":"2010","unstructured":"Staudt LM. Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol. 2010;2(6): a000109.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8","key":"3673_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ni.2060","volume":"12","author":"Y Ben-Neriah","year":"2011","unstructured":"Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-\u03baB as the matchmaker. Nat Immunol. 2011;12(8):715\u201323.","journal-title":"Nat Immunol"},{"issue":"12","key":"3673_CR25","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1136\/gutjnl-2022-329349","volume":"72","author":"X Liu","year":"2023","unstructured":"Liu X, et al. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-\u03baB\/p65 nuclear translocation in pancreatic ductal adenocarcinoma. Gut. 2023;72(12):2329\u201343.","journal-title":"Gut"},{"issue":"11","key":"3673_CR26","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1016\/j.ymthe.2023.09.010","volume":"31","author":"R Sun","year":"2023","unstructured":"Sun R, et al. CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3\/NF-\u03baB\/SDF-1\u03b1 axis to enhance efficacy against pancreatic cancer. Mol Ther. 2023;31(11):3193\u2013209.","journal-title":"Mol Ther"},{"issue":"16","key":"3673_CR27","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1158\/0008-5472.CAN-20-3929","volume":"81","author":"SB Kemp","year":"2021","unstructured":"Kemp SB, et al. Apolipoprotein E promotes immune suppression in pancreatic cancer through NF-\u03baB-mediated production of CXCL1. Cancer Res. 2021;81(16):4305\u201318.","journal-title":"Cancer Res"},{"issue":"8","key":"3673_CR28","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41416-022-01927-y","volume":"127","author":"T Zhao","year":"2022","unstructured":"Zhao T, et al. ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1\u03b2\/NF-\u03baB\/ESE3 signalling axis. Br J Cancer. 2022;127(8):1461\u201372.","journal-title":"Br J Cancer"},{"issue":"1","key":"3673_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s10020-023-00648-z","volume":"29","author":"J Jiao","year":"2023","unstructured":"Jiao J, et al. Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-\u03baB\/JNK\/ERK phosphorylation. Mol Med. 2023;29(1):47.","journal-title":"Mol Med"},{"issue":"5","key":"3673_CR30","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2017.12.004","volume":"154","author":"X Song","year":"2018","unstructured":"Song X, et al. JTC801 induces pH-dependent death specifically in cancer cells and slows growth of tumors in mice. Gastroenterology. 2018;154(5):1480\u201393.","journal-title":"Gastroenterology"},{"issue":"1","key":"3673_CR31","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41598-023-28261-4","volume":"13","author":"D Que","year":"2023","unstructured":"Que D, et al. ACSS2-mediated NF-\u03baB activation promotes alkaliptosis in human pancreatic cancer cells. Sci Rep. 2023;13(1):1483.","journal-title":"Sci Rep"},{"issue":"5","key":"3673_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12816","volume":"53","author":"Q Sun","year":"2020","unstructured":"Sun Q, et al. Pin1 promotes pancreatic cancer progression and metastasis by activation of NF-\u03baB-IL-18 feedback loop. Cell Prolif. 2020;53(5): e12816.","journal-title":"Cell Prolif"},{"issue":"3","key":"3673_CR33","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.7150\/ijbs.66313","volume":"18","author":"J Chen","year":"2022","unstructured":"Chen J, et al. VRK2 activates TNF\u03b1\/NF-\u03baB signaling by phosphorylating IKK\u03b2 in pancreatic cancer. Int J Biol Sci. 2022;18(3):1288\u2013302.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"3673_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/carcin\/bgac042","volume":"43","author":"J Li","year":"2022","unstructured":"Li J, et al. HOXA10 promote pancreatic cancer progression via directly activating canonical NF-\u03baB signaling pathway. Carcinogenesis. 2022;43(8):787\u201396.","journal-title":"Carcinogenesis"},{"key":"3673_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.canlet.2019.03.025","volume":"452","author":"L Yin","year":"2019","unstructured":"Yin L, et al. MicroRNA-365a-3p inhibits c-Rel-mediated NF-\u03baB signaling and the progression of pancreatic cancer. Cancer Lett. 2019;452:203\u201312.","journal-title":"Cancer Lett"},{"issue":"4","key":"3673_CR36","doi-asserted-by":"publisher","first-page":"109406","DOI":"10.1016\/j.isci.2024.109406","volume":"27","author":"R Wang","year":"2024","unstructured":"Wang R, et al. The NF-\u03baB\/NUAK2 signaling axis regulates pancreatic cancer progression by targeting SMAD2\/3. iScience. 2024;27(4):109406.","journal-title":"iScience"},{"issue":"7","key":"3673_CR37","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.7150\/thno.51976","volume":"11","author":"K Li","year":"2021","unstructured":"Li K, et al. Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin a secretion via NF-\u03baB inhibition. Theranostics. 2021;11(7):3196\u2013212.","journal-title":"Theranostics"},{"issue":"9","key":"3673_CR38","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.7150\/thno.40566","volume":"10","author":"Q Meng","year":"2020","unstructured":"Meng Q, et al. A miR-146a-5p\/TRAF6\/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance. Theranostics. 2020;10(9):3967\u201379.","journal-title":"Theranostics"},{"key":"3673_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2019.115223","volume":"225","author":"X Xie","year":"2019","unstructured":"Xie X, et al. Polysaccharide enhanced NK cell cytotoxicity against pancreatic cancer via TLR4\/MAPKs\/NF-\u03baB pathway in vitro\/vivo. Carbohydr Polym. 2019;225: 115223.","journal-title":"Carbohydr Polym"},{"issue":"3","key":"3673_CR40","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.pan.2021.01.023","volume":"21","author":"Z Ruan","year":"2021","unstructured":"Ruan Z, et al. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-\u03baB\/STAT3 and NF-\u03baB\/CSN5 signaling pathways. Pancreatology. 2021;21(3):630\u201341.","journal-title":"Pancreatology"},{"key":"3673_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115057","volume":"201","author":"YB Du","year":"2022","unstructured":"Du YB, et al. The recombinant defensin\/HSA fusion protein that inhibits NF-\u03bab associated with intensive macropinocytosis shows potent efficacy against pancreatic cancer. Biochem Pharmacol. 2022;201: 115057.","journal-title":"Biochem Pharmacol"},{"key":"3673_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114076","volume":"158","author":"H Mostafa","year":"2023","unstructured":"Mostafa H, et al. Plasma anthocyanins and their metabolites reduce in vitro migration of pancreatic cancer cells, PANC-1, in a FAK- and NF-kB dependent manner: Results from the ATTACH-study a randomized, controlled, crossover trial in healthy subjects. Biomed Pharmacother. 2023;158: 114076.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"3673_CR43","first-page":"3750","volume":"11","author":"JX Ma","year":"2019","unstructured":"Ma JX, et al. Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4\/NF-\u03baB signaling. Am J Transl Res. 2019;11(6):3750\u201360.","journal-title":"Am J Transl Res"},{"issue":"25","key":"3673_CR44","doi-asserted-by":"publisher","first-page":"255101","DOI":"10.1088\/1361-6528\/ad312a","volume":"35","author":"Y Chen","year":"2024","unstructured":"Chen Y, et al. Novel silicene-mesoporous silica nanoparticles conjugated gemcitabine induced cellular apoptosis via upregulating NF-\u03baB p65 nuclear translocation suppresses pancreatic cancer growthin vitroandin vivo. Nanotechnology. 2024;35(25):255101.","journal-title":"Nanotechnology"},{"key":"3673_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154564","volume":"109","author":"T Lan","year":"2023","unstructured":"Lan T, et al. Cinobufacini retards progression of pancreatic ductal adenocarcinoma through targeting YEATS2\/TAK1\/NF-\u03baB axis. Phytomedicine. 2023;109: 154564.","journal-title":"Phytomedicine"},{"issue":"1","key":"3673_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13046-021-02237-6","volume":"41","author":"S Zheng","year":"2022","unstructured":"Zheng S, et al. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-\u03baB signaling pathway. J Exp Clin Cancer Res. 2022;41(1):71.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"3673_CR47","doi-asserted-by":"publisher","first-page":"e004258","DOI":"10.1136\/jitc-2021-004258","volume":"10","author":"A Sorrentino","year":"2022","unstructured":"Sorrentino A, et al. Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-\u03baB activation. J Immunother Cancer. 2022;10(5):e004258. https:\/\/doi.org\/10.1136\/jitc-2021-004258.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"3673_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40425-019-0521-4","volume":"7","author":"E Brunetto","year":"2019","unstructured":"Brunetto E, et al. The IL-1\/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer. J Immunother Cancer. 2019;7(1):45.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"3673_CR49","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.bcp.2011.07.063","volume":"82","author":"J Hoffmann","year":"2011","unstructured":"Hoffmann J, et al. EGCG downregulates IL-1RI expression and suppresses IL-1-induced tumorigenic factors in human pancreatic adenocarcinoma cells. Biochem Pharmacol. 2011;82(9):1153\u201362.","journal-title":"Biochem Pharmacol"},{"key":"3673_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216403","volume":"575","author":"J Yang","year":"2023","unstructured":"Yang J, et al. FABP4 in macrophages facilitates obesity-associated pancreatic cancer progression via the NLRP3\/IL-1\u03b2 axis. Cancer Lett. 2023;575: 216403.","journal-title":"Cancer Lett"},{"key":"3673_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108429","volume":"102","author":"J Wu","year":"2022","unstructured":"Wu J, et al. TNFSF9 promotes metastasis of pancreatic cancer by regulating M2 polarization of macrophages through Src\/FAK\/p-Akt\/IL-1\u03b2 signaling. Int Immunopharmacol. 2022;102: 108429.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"3673_CR52","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/gutjnl-2016-311585","volume":"67","author":"TA Mace","year":"2018","unstructured":"Mace TA, et al. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer. Gut. 2018;67(2):320\u201332.","journal-title":"Gut"},{"issue":"12","key":"3673_CR53","first-page":"5992","volume":"11","author":"S Wang","year":"2021","unstructured":"Wang S, et al. Paracrine production of IL-6 promotes a hypercoagulable state in pancreatic cancer. Am J Cancer Res. 2021;11(12):5992\u20136003.","journal-title":"Am J Cancer Res"},{"key":"3673_CR54","doi-asserted-by":"publisher","first-page":"e78921","DOI":"10.7554\/eLife.78921","volume":"11","author":"I de Castro Silva","year":"2022","unstructured":"de Castro Silva I, et al. Neutrophil-mediated fibroblast-tumor cell il-6\/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: A hybrid clinical-preclinical study. Elife. 2022;11:e78921.","journal-title":"Elife"},{"issue":"6","key":"3673_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13107","volume":"94","author":"V Sharma","year":"2021","unstructured":"Sharma V, et al. IL-6 is associated with expansion of myeloid-derived suppressor cells and enhanced immunosuppression in pancreatic adenocarcinoma patients. Scand J Immunol. 2021;94(6): e13107.","journal-title":"Scand J Immunol"},{"issue":"5","key":"3673_CR56","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/MPA.0b013e31823cdd10","volume":"41","author":"KM Block","year":"2012","unstructured":"Block KM, et al. IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines. Pancreas. 2012;41(5):773\u201381.","journal-title":"Pancreas"},{"issue":"10","key":"3673_CR57","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.3390\/cancers12102969","volume":"12","author":"M Hilmi","year":"2020","unstructured":"Hilmi M, et al. Cancer-associated fibroblasts: accomplices in the tumor immune evasion. Cancers (Basel). 2020;12(10):2969. https:\/\/doi.org\/10.3390\/cancers12102969.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"3673_CR58","doi-asserted-by":"publisher","first-page":"e006130","DOI":"10.1136\/jitc-2022-006130","volume":"11","author":"YE Lee","year":"2023","unstructured":"Lee YE, et al. Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6. J Immunother Cancer. 2023;11(2):e006130. https:\/\/doi.org\/10.1136\/jitc-2022-006130.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"3673_CR59","first-page":"255","volume":"39","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. IL-6 accelerates the proliferation and metastasis of pancreatic cancer cells via the miR-455-5p\/IGF-1R Axis. Cancer Biother Radiopharm. 2024;39(4):255\u201363.","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"3673_CR60","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3390\/cancers12020329","volume":"12","author":"PW Underwood","year":"2020","unstructured":"Underwood PW, et al. Nicotine induces IL-8 secretion from pancreatic cancer stroma and worsens cancer-induced cachexia. Cancers (Basel). 2020;12(2):329. https:\/\/doi.org\/10.3390\/cancers12020329.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3673_CR61","first-page":"142","volume":"55","author":"Y Chen","year":"2019","unstructured":"Chen Y, et al. MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer. Int J Oncol. 2019;55(1):142\u201356.","journal-title":"Int J Oncol"},{"key":"3673_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216784","volume":"588","author":"Z Zhong","year":"2024","unstructured":"Zhong Z, et al. Tumor-associated macrophages drive glycolysis through the IL-8\/STAT3\/GLUT3 signaling pathway in pancreatic cancer progression. Cancer Lett. 2024;588: 216784.","journal-title":"Cancer Lett"},{"key":"3673_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215722","volume":"539","author":"P Li","year":"2022","unstructured":"Li P, et al. Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model. Cancer Lett. 2022;539: 215722.","journal-title":"Cancer Lett"},{"issue":"6","key":"3673_CR64","first-page":"3508","volume":"41","author":"H Imafuji","year":"2019","unstructured":"Imafuji H, et al. Acquisition of gemcitabine resistance enhances angiogenesis via upregulation of IL-8 production in pancreatic cancer. Oncol Rep. 2019;41(6):3508\u201316.","journal-title":"Oncol Rep"},{"issue":"11","key":"3673_CR65","doi-asserted-by":"publisher","first-page":"1693-1704","DOI":"10.1038\/s41587-023-02060-8","volume":"42","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, et al. IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases. Nat Biotechnol. 2024;42(11):1693-1704. https:\/\/doi.org\/10.1038\/s41587-023-02060-8.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"3673_CR66","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/labinvest.2013.69","volume":"93","author":"CY Liu","year":"2013","unstructured":"Liu CY, et al. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4\/IL-10 signaling pathway. Lab Invest. 2013;93(7):844\u201354.","journal-title":"Lab Invest"},{"issue":"11","key":"3673_CR67","doi-asserted-by":"publisher","first-page":"11467","DOI":"10.1007\/s13277-014-2459-y","volume":"35","author":"C Ren","year":"2014","unstructured":"Ren C, et al. Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer. Tumour Biol. 2014;35(11):11467\u201372.","journal-title":"Tumour Biol"},{"issue":"11","key":"3673_CR68","first-page":"3551","volume":"10","author":"F Hu","year":"2020","unstructured":"Hu F, et al. IL-17 in pancreatic disease: pathogenesis and pharmacotherapy. Am J Cancer Res. 2020;10(11):3551\u201364.","journal-title":"Am J Cancer Res"},{"issue":"11","key":"3673_CR69","doi-asserted-by":"publisher","first-page":"7424","DOI":"10.3390\/ijms12117424","volume":"12","author":"S He","year":"2011","unstructured":"He S, et al. Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients. Int J Mol Sci. 2011;12(11):7424\u201337.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3673_CR70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12029-015-9787-z","volume":"47","author":"S Karabulut","year":"2016","unstructured":"Karabulut S, et al. Evaluation of serum interleukin-17 (IL-17) levels as a diagnostic marker in pancreatic adenocarcinoma. J Gastrointest Cancer. 2016;47(1):47\u201354.","journal-title":"J Gastrointest Cancer"},{"issue":"2","key":"3673_CR71","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3892\/ijo.2017.4032","volume":"51","author":"C Liu","year":"2017","unstructured":"Liu C, et al. Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer. Int J Oncol. 2017;51(2):686\u201394.","journal-title":"Int J Oncol"},{"issue":"5","key":"3673_CR72","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.ccr.2014.03.014","volume":"25","author":"F McAllister","year":"2014","unstructured":"McAllister F, et al. Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. Cancer Cell. 2014;25(5):621\u201337.","journal-title":"Cancer Cell"},{"issue":"20","key":"3673_CR73","doi-asserted-by":"publisher","first-page":"9530","DOI":"10.18632\/oncotarget.2618","volume":"5","author":"F McAllister","year":"2014","unstructured":"McAllister F, Leach SD. Targeting IL-17 for pancreatic cancer prevention. Oncotarget. 2014;5(20):9530\u20131.","journal-title":"Oncotarget"},{"issue":"7","key":"3673_CR74","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd4372","volume":"13","author":"M Cully","year":"2014","unstructured":"Cully M. Targeting IL-17 in pancreatic cancer. Nat Rev Drug Discovery. 2014;13(7):493\u2013493.","journal-title":"Nat Rev Drug Discovery"},{"key":"3673_CR75","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.canlet.2018.01.017","volume":"418","author":"K Fan","year":"2018","unstructured":"Fan K, et al. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer. Cancer Lett. 2018;418:167\u201375.","journal-title":"Cancer Lett"},{"issue":"7","key":"3673_CR76","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/carcin\/bgr075","volume":"32","author":"U Bharadwaj","year":"2011","unstructured":"Bharadwaj U, et al. Mesothelin overexpression promotes autocrine IL-6\/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation. Carcinogenesis. 2011;32(7):1013\u201324.","journal-title":"Carcinogenesis"},{"key":"3673_CR77","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.2147\/OTT.S136840","volume":"10","author":"D Yu","year":"2017","unstructured":"Yu D, et al. Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells. Onco Targets Ther. 2017;10:4719\u201329.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"3673_CR78","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/ijc.29445","volume":"137","author":"FA Goumas","year":"2015","unstructured":"Goumas FA, et al. Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer. Int J Cancer. 2015;137(5):1035\u201346.","journal-title":"Int J Cancer"},{"issue":"5","key":"3673_CR79","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1158\/1078-0432.CCR-09-2405","volume":"16","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, et al. ZIP4 regulates pancreatic cancer cell growth by activating IL-6\/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res. 2010;16(5):1423\u201330.","journal-title":"Clin Cancer Res"},{"issue":"6c","key":"3673_CR80","first-page":"4093","volume":"22","author":"T Masui","year":"2002","unstructured":"Masui T, et al. Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction. Anticancer Res. 2002;22(6c):4093\u2013100.","journal-title":"Anticancer Res"},{"issue":"1","key":"3673_CR81","doi-asserted-by":"publisher","first-page":"1845424","DOI":"10.1080\/2162402X.2020.1845424","volume":"9","author":"F Marcon","year":"2020","unstructured":"Marcon F, et al. NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype. Oncoimmunology. 2020;9(1):1845424.","journal-title":"Oncoimmunology"},{"issue":"10","key":"3673_CR82","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/bjc.2013.174","volume":"108","author":"S Mitsunaga","year":"2013","unstructured":"Mitsunaga S, et al. Serum levels of IL-6 and IL-1\u03b2 can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer. 2013;108(10):2063\u20139.","journal-title":"Br J Cancer"},{"issue":"28","key":"3673_CR83","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1038\/sj.onc.1209423","volume":"25","author":"SS M\u00fcerk\u00f6ster","year":"2006","unstructured":"M\u00fcerk\u00f6ster SS, et al. Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1beta and NO lead to inactivation of caspases. Oncogene. 2006;25(28):3973\u201381.","journal-title":"Oncogene"},{"issue":"4","key":"3673_CR84","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ijc.24040","volume":"124","author":"Y Matsuo","year":"2009","unstructured":"Matsuo Y, et al. CXCL8\/IL-8 and CXCL12\/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer. 2009;124(4):853\u201361.","journal-title":"Int J Cancer"},{"issue":"24","key":"3673_CR85","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.7150\/thno.36830","volume":"9","author":"HC Wang","year":"2019","unstructured":"Wang HC, et al. Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8. Theranostics. 2019;9(24):7168\u201383.","journal-title":"Theranostics"},{"issue":"6","key":"3673_CR86","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.surg.2006.12.016","volume":"141","author":"JJ Grzesiak","year":"2007","unstructured":"Grzesiak JJ, et al. Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells. Surgery. 2007;141(6):804\u201314.","journal-title":"Surgery"},{"issue":"9","key":"3673_CR87","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41419-018-0874-5","volume":"9","author":"C Li","year":"2018","unstructured":"Li C, et al. BAG3 regulates stability of IL-8 mRNA via interplay between HuR and miR-4312 in PDACs. Cell Death Dis. 2018;9(9):863.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3673_CR88","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1499-3872(13)60012-0","volume":"12","author":"DH Zhou","year":"2013","unstructured":"Zhou DH, et al. TRAIL-induced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells. Hepatobiliary Pancreat Dis Int. 2013;12(1):94\u20138.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"10","key":"3673_CR89","first-page":"Br343","volume":"11","author":"H Sawai","year":"2005","unstructured":"Sawai H, et al. Interleukin-1alpha enhances IL-8 secretion through p38 mitogen-activated protein kinase and reactive oxygen species signaling in human pancreatic cancer cells. Med Sci Monit. 2005;11(10):Br343-50.","journal-title":"Med Sci Monit"},{"issue":"8","key":"3673_CR90","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.3390\/cells10081928","volume":"10","author":"L Magni","year":"2021","unstructured":"Magni L, et al. The P2X7 receptor stimulates IL-6 release from pancreatic stellate cells and tocilizumab prevents activation of STAT3 in pancreatic cancer cells. Cells. 2021;10(8):1928.","journal-title":"Cells"},{"issue":"7","key":"3673_CR91","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jcyt.2021.12.005","volume":"24","author":"R Antoon","year":"2022","unstructured":"Antoon R, et al. Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell-derived IL-6 is reversed predominantly by IL-6 blockade. Cytotherapy. 2022;24(7):699\u2013710.","journal-title":"Cytotherapy"},{"issue":"5","key":"3673_CR92","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2174\/1568009618666180430123939","volume":"19","author":"X Chen","year":"2019","unstructured":"Chen X, et al. Blocking IL-6\/GP130 signaling inhibits cell viability\/proliferation, glycolysis, and colony forming activity in human pancreatic cancer cells. Curr Cancer Drug Targets. 2019;19(5):417\u201327.","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"3673_CR93","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41575-019-0138-6","volume":"16","author":"H Thomas","year":"2019","unstructured":"Thomas H. IL-6 drives niche formation in pancreatic cancer liver metastasis. Nat Rev Gastroenterol Hepatol. 2019;16(5):263.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"3673_CR94","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13237","volume":"55","author":"Y Huo","year":"2022","unstructured":"Huo Y, et al. Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL-6 trans-signalling. Cell Prolif. 2022;55(5): e13237.","journal-title":"Cell Prolif"},{"issue":"2","key":"3673_CR95","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.canlet.2016.04.013","volume":"376","author":"B Hu","year":"2016","unstructured":"Hu B, et al. HIC1 attenuates invasion and metastasis by inhibiting the IL-6\/STAT3 signalling pathway in human pancreatic cancer. Cancer Lett. 2016;376(2):387\u201398.","journal-title":"Cancer Lett"},{"issue":"1","key":"3673_CR96","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3892\/or.2020.7600","volume":"44","author":"W Li","year":"2020","unstructured":"Li W, et al. Curcumin inhibits pancreatic cancer cell invasion and EMT by interfering with tumor-stromal crosstalk under hypoxic conditions via the IL-6\/ERK\/NF-\u03baB axis. Oncol Rep. 2020;44(1):382\u201392.","journal-title":"Oncol Rep"},{"issue":"4","key":"3673_CR97","first-page":"1892","volume":"39","author":"X Zhang","year":"2018","unstructured":"Zhang X, et al. Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6\/JAK2\/STAT3 signaling. Oncol Rep. 2018;39(4):1892\u2013900.","journal-title":"Oncol Rep"},{"key":"3673_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176357","volume":"967","author":"N Song","year":"2024","unstructured":"Song N, et al. Advance in the role of chemokines\/chemokine receptors in carcinogenesis: Focus on pancreatic cancer. Eur J Pharmacol. 2024;967: 176357.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"3673_CR99","first-page":"295","volume":"83","author":"L Feng","year":"2020","unstructured":"Feng L, et al. Serum level of CCL2 predicts outcome of patients with pancreatic cancer. Acta Gastro-enterol Belg. 2020;83(2):295\u20139.","journal-title":"Acta Gastro-enterol Belg"},{"issue":"4","key":"3673_CR100","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/iid3.523","volume":"9","author":"H Gu","year":"2021","unstructured":"Gu H, et al. CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid-derived suppressor cells. Immun Inflamm Dis. 2021;9(4):1686\u201395.","journal-title":"Immun Inflamm Dis"},{"key":"3673_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108598","volume":"106","author":"X Li","year":"2022","unstructured":"Li X, et al. CCL2-mediated monocytes regulate immune checkpoint blockade resistance in pancreatic cancer. Int Immunopharmacol. 2022;106: 108598.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"3673_CR102","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.trecan.2020.02.020","volume":"6","author":"EC Madden","year":"2020","unstructured":"Madden EC, et al. Tumour cell secretome in chemoresistance and tumour recurrence. Trends Cancer. 2020;6(6):489\u2013505.","journal-title":"Trends Cancer"},{"key":"3673_CR103","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3389\/fimmu.2020.00901","volume":"11","author":"ME Reyes","year":"2020","unstructured":"Reyes ME, et al. Role of CC chemokines subfamily in the platinum drugs resistance promotion in cancer. Front Immunol. 2020;11:901.","journal-title":"Front Immunol"},{"issue":"10","key":"3673_CR104","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/cancers11101445","volume":"11","author":"C Geismann","year":"2019","unstructured":"Geismann C, et al. NF-\u03baB dependent chemokine signaling in pancreatic cancer. Cancers (Basel). 2019;11(10):1445.","journal-title":"Cancers (Basel)"},{"key":"3673_CR105","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1158\/1538-7445.AM2021-1087","volume":"81","author":"C Molczyk","year":"2021","unstructured":"Molczyk C, et al. CXCR2 and its ligands modulate chemotherapy resistance in pancreatic ductal adenocarcinoma. Cancer Res. 2021;81:1087\u20131087.","journal-title":"Cancer Res"},{"key":"3673_CR106","volume-title":"Seminars in cancer biology","author":"SK Gautam","year":"2022","unstructured":"Gautam SK, et al. Regulation of pancreatic cancer therapy resistance by chemokines. In: Seminars in cancer biology. Amsterdam: Elsevier; 2022."},{"issue":"11","key":"3673_CR107","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1038\/sj.bjc.6605968","volume":"103","author":"S Singh","year":"2010","unstructured":"Singh S, et al. CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy. Br J Cancer. 2010;103(11):1671\u20139.","journal-title":"Br J Cancer"},{"issue":"11","key":"3673_CR108","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1136\/gutjnl-2018-317479","volume":"68","author":"SH Jiang","year":"2019","unstructured":"Jiang SH, et al. GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca(2+) signalling in a GABA-independent manner. Gut. 2019;68(11):1994\u20132006.","journal-title":"Gut"},{"issue":"3","key":"3673_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090400","volume":"9","author":"I Roy","year":"2014","unstructured":"Roy I, et al. CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. PLoS ONE. 2014;9(3): e90400.","journal-title":"PLoS ONE"},{"key":"3673_CR110","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1479-5876-10-68","volume":"10","author":"EL Heinrich","year":"2012","unstructured":"Heinrich EL, et al. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells. J Transl Med. 2012;10:68.","journal-title":"J Transl Med"},{"issue":"1","key":"3673_CR111","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MPA.0b013e3181bb2ab7","volume":"39","author":"X Shen","year":"2010","unstructured":"Shen X, et al. Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways. Pancreas. 2010;39(1):81\u20137.","journal-title":"Pancreas"},{"issue":"3","key":"3673_CR112","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12307-013-0130-6","volume":"6","author":"EL Heinrich","year":"2013","unstructured":"Heinrich EL, et al. Paracrine activation of chemokine receptor CCR9 enhances the invasiveness of pancreatic cancer cells. Cancer Microenviron. 2013;6(3):241\u20135.","journal-title":"Cancer Microenviron"},{"key":"3673_CR113","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ejphar.2017.11.019","volume":"818","author":"H Han","year":"2018","unstructured":"Han H, et al. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes. Eur J Pharmacol. 2018;818:593\u2013603.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"3673_CR114","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/ijc.24383","volume":"125","author":"Y Matsuo","year":"2009","unstructured":"Matsuo Y, et al. CXC-chemokine\/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. Int J Cancer. 2009;125(5):1027\u201337.","journal-title":"Int J Cancer"},{"issue":"11","key":"3673_CR115","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s11605-009-1002-8","volume":"13","author":"X Shen","year":"2009","unstructured":"Shen X, et al. CC chemokine receptor 9 enhances proliferation in pancreatic intraepithelial neoplasia and pancreatic cancer cells. J Gastrointest Surg. 2009;13(11):1955\u201362.","journal-title":"J Gastrointest Surg"},{"key":"3673_CR116","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.biomaterials.2016.05.042","volume":"101","author":"Y Wang","year":"2016","unstructured":"Wang Y, et al. Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis. Biomaterials. 2016;101:108\u201320.","journal-title":"Biomaterials"},{"issue":"2","key":"3673_CR117","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3892\/ol.2015.3344","volume":"10","author":"JS Sun","year":"2015","unstructured":"Sun JS, et al. Hypoxia promotes C-X-C chemokine receptor type 4 expression through microRNA-150 in pancreatic cancer cells. Oncol Lett. 2015;10(2):835\u201340.","journal-title":"Oncol Lett"},{"issue":"19","key":"3673_CR118","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.3748\/wjg.v20.i19.5808","volume":"20","author":"J Vaz","year":"2014","unstructured":"Vaz J, Andersson R. Intervention on toll-like receptors in pancreatic cancer. World J Gastroenterol. 2014;20(19):5808\u201317.","journal-title":"World J Gastroenterol"},{"issue":"23","key":"3673_CR119","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.3748\/wjg.v16.i23.2881","volume":"16","author":"J-J Zhang","year":"2010","unstructured":"Zhang J-J, et al. Expression and significance of TLR4 and HIF-1\u03b1 in pancreatic ductal adenocarcinoma. World J Gastroenterol. 2010;16(23):2881\u20138.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3673_CR120","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbrc.2017.01.051","volume":"484","author":"MJ Binker-Cosen","year":"2017","unstructured":"Binker-Cosen MJ, et al. Palmitic acid increases invasiveness of pancreatic cancer cells AsPC-1 through TLR4\/ROS\/NF-\u03baB\/MMP-9 signaling pathway. Biochem Biophys Res Commun. 2017;484(1):152\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3673_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167183","volume":"1870","author":"H Cai","year":"2024","unstructured":"Cai H, et al. Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis. Biochim Biophys Acta Mol Basis Dis. 2024;1870(5): 167183.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"3673_CR122","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/antib13010011","volume":"13","author":"AK Ajay","year":"2024","unstructured":"Ajay AK, et al. TLR2 and TLR9 blockade using specific intrabodies inhibits inflammation-mediated pancreatic cancer cell growth. Antibodies (Basel). 2024;13(1):11. https:\/\/doi.org\/10.3390\/antib13010011.","journal-title":"Antibodies (Basel)"},{"issue":"9","key":"3673_CR123","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/jitc-2021-002876","volume":"9","author":"C Carbone","year":"2021","unstructured":"Carbone C, et al. Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer. J Immunother Cancer. 2021;9(9):3.","journal-title":"J Immunother Cancer"},{"issue":"7","key":"3673_CR124","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/intimm\/dxac012","volume":"34","author":"B Temizoz","year":"2022","unstructured":"Temizoz B, et al. Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation. Int Immunol. 2022;34(7):353\u201364.","journal-title":"Int Immunol"},{"issue":"1","key":"3673_CR125","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12935-023-03167-3","volume":"23","author":"W Zhang","year":"2023","unstructured":"Zhang W, Liu W, Hu X. Robinin inhibits pancreatic cancer cell proliferation, EMT and inflammation via regulating TLR2-PI3k-AKT signaling pathway. Cancer Cell Int. 2023;23(1):328.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"3673_CR126","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41419-019-1956-8","volume":"10","author":"L Zhang","year":"2019","unstructured":"Zhang L, et al. Dedifferentiation process driven by radiotherapy-induced HMGB1\/TLR2\/YAP\/HIF-1\u03b1 signaling enhances pancreatic cancer stemness. Cell Death Dis. 2019;10(10):724.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3673_CR127","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1186\/s12885-023-11557-z","volume":"23","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, et al. Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis. BMC Cancer. 2023;23(1):1044.","journal-title":"BMC Cancer"},{"issue":"19","key":"3673_CR128","doi-asserted-by":"publisher","first-page":"11414","DOI":"10.3390\/ijms231911414","volume":"23","author":"SE Youn","year":"2022","unstructured":"Youn SE, et al. PAUF induces migration of human pancreatic cancer cells exclusively via the TLR4\/MyD88\/NF-\u03baB signaling pathway. Int J Mol Sci. 2022;23(19):11414.","journal-title":"Int J Mol Sci"},{"key":"3673_CR129","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.biocel.2019.01.011","volume":"108","author":"J Zhao","year":"2019","unstructured":"Zhao J, et al. B7\u2013H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. Int J Biochem Cell Biol. 2019;108:84\u201391.","journal-title":"Int J Biochem Cell Biol"},{"issue":"179","key":"3673_CR130","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.24976\/Discov.Med.202335179.105","volume":"35","author":"X Zhou","year":"2023","unstructured":"Zhou X, Wang W, Liu L. Somatostatin inhibited the EMT of pancreatic cancer cells by mediating the TGF-\u03b2\/smad signaling pathway. Discov Med. 2023;35(179):1086\u201392.","journal-title":"Discov Med"},{"issue":"1","key":"3673_CR131","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3892\/or.2020.7595","volume":"44","author":"J Yoshida","year":"2020","unstructured":"Yoshida J, et al. Metformin inhibits TGF-\u03b21-induced epithelial-mesenchymal transition and liver metastasis of pancreatic cancer cells. Oncol Rep. 2020;44(1):371\u201381.","journal-title":"Oncol Rep"},{"key":"3673_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107274","volume":"146","author":"J Zhao","year":"2024","unstructured":"Zhao J, et al. Riboflavin protects against pancreatic cancer metastasis by targeting TGF-\u03b2 receptor 1. Bioorg Chem. 2024;146: 107274.","journal-title":"Bioorg Chem"},{"issue":"1","key":"3673_CR133","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s10020-022-00509-1","volume":"28","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Xu Y. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-\u03b2\/SMAD3 signaling. Mol Med. 2022;28(1):82.","journal-title":"Mol Med"},{"issue":"5","key":"3673_CR134","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1002\/cam4.5397","volume":"12","author":"HJ Xu","year":"2023","unstructured":"Xu HJ, et al. ESE1\/AGR2 axis antagonizes TGF-\u03b2-induced epithelial-mesenchymal transition in low-grade pancreatic cancer. Cancer Med. 2023;12(5):5979\u201393.","journal-title":"Cancer Med"},{"issue":"8","key":"3673_CR135","doi-asserted-by":"publisher","first-page":"13651","DOI":"10.1002\/jcb.28638","volume":"120","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, et al. Upregulation of LASP2 inhibits pancreatic cancer cell migration and invasion through suppressing TGF-\u03b2-induced EMT. J Cell Biochem. 2019;120(8):13651\u20137.","journal-title":"J Cell Biochem"},{"key":"3673_CR136","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2147\/CMAR.S224416","volume":"12","author":"CS Cheng","year":"2020","unstructured":"Cheng CS, et al. Paeonol inhibits pancreatic cancer cell migration and invasion through the inhibition of TGF-\u03b21\/smad signaling and epithelial-mesenchymal-transition. Cancer Manag Res. 2020;12:641\u201351.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"3673_CR137","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10565-020-09562-0","volume":"37","author":"Y Guo","year":"2021","unstructured":"Guo Y, et al. Quercetin suppresses pancreatic ductal adenocarcinoma progression via inhibition of SHH and TGF-\u03b2\/Smad signaling pathways. Cell Biol Toxicol. 2021;37(3):479\u201396.","journal-title":"Cell Biol Toxicol"},{"issue":"7","key":"3673_CR138","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1053\/j.gastro.2022.02.017","volume":"162","author":"X Shi","year":"2022","unstructured":"Shi X, et al. Circular RNA ANAPC7 inhibits tumor growth and muscle wasting via PHLPP2-AKT-TGF-\u03b2 signaling axis in pancreatic cancer. Gastroenterology. 2022;162(7):2004-2017.e2.","journal-title":"Gastroenterology"},{"issue":"4","key":"3673_CR139","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ccell.2020.08.015","volume":"38","author":"L Gabitova-Cornell","year":"2020","unstructured":"Gabitova-Cornell L, et al. Cholesterol pathway inhibition induces TGF-\u03b2 signaling to promote basal differentiation in pancreatic cancer. Cancer Cell. 2020;38(4):567-583.e11.","journal-title":"Cancer Cell"},{"issue":"1","key":"3673_CR140","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12943-023-01847-2","volume":"22","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, et al. circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-\u03b2 signalling pathway-mediated activation of MMPs in pancreatic cancer. Mol Cancer. 2023;22(1):152.","journal-title":"Mol Cancer"},{"issue":"2","key":"3673_CR141","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41419-022-04609-y","volume":"13","author":"W Sheng","year":"2022","unstructured":"Sheng W, et al. Numb-PRRL promotes TGF-\u03b21- and EGF-induced epithelial-to-mesenchymal transition in pancreatic cancer. Cell Death Dis. 2022;13(2):173.","journal-title":"Cell Death Dis"},{"issue":"7","key":"3673_CR142","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/biology10070597","volume":"10","author":"G Gao","year":"2021","unstructured":"Gao G, Chen J, Wang D, Li Q, Yang X, Wang J, Pan Z, Xiao ZJ, Yi Y. TGF-\u03b21 facilitates TAp63\u03b1 protein lysosomal degradation to promote pancreatic cancer cell migration. Biology (Basel). 2021;10(7):597. https:\/\/doi.org\/10.3390\/biology10070597.","journal-title":"Biology (Basel)"},{"issue":"4","key":"3673_CR143","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3892\/or.2014.3012","volume":"39","author":"K Chen","year":"2018","unstructured":"Chen K, et al. Itraconazole inhibits invasion and migration of pancreatic cancer cells by suppressing TGF-\u03b2\/SMAD2\/3 signaling. Oncol Rep. 2018;39(4):1573\u201382.","journal-title":"Oncol Rep"},{"key":"3673_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.597672","volume":"10","author":"S Chen","year":"2020","unstructured":"Chen S, et al. Magnolol suppresses pancreatic cancer development in vivo and in vitro via negatively regulating TGF-\u03b2\/smad signaling. Front Oncol. 2020;10: 597672.","journal-title":"Front Oncol"},{"key":"3673_CR145","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","volume":"170","author":"HJ Patel","year":"2017","unstructured":"Patel HJ, Patel BM. TNF-\u03b1 and cancer cachexia: molecular insights and clinical implications. Life Sci. 2017;170:56\u201363.","journal-title":"Life Sci"},{"issue":"6","key":"3673_CR146","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1158\/2159-8290.CD-22-1046","volume":"13","author":"A Bianchi","year":"2023","unstructured":"Bianchi A, et al. Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer. Cancer Discov. 2023;13(6):1428\u201353.","journal-title":"Cancer Discov"},{"key":"3673_CR147","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.153242","author":"A Dixit","year":"2022","unstructured":"Dixit A, et al. Targeting TNF-\u03b1-producing macrophages activates antitumor immunity in pancreatic cancer via IL-33 signaling. JCI Insight. 2022. https:\/\/doi.org\/10.1172\/jci.insight.153242.","journal-title":"JCI Insight"},{"issue":"11","key":"3673_CR148","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s43018-021-00258-w","volume":"2","author":"M Tu","year":"2021","unstructured":"Tu M, et al. TNF-\u03b1-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer. Nat Cancer. 2021;2(11):1185\u2013203.","journal-title":"Nat Cancer"},{"issue":"1","key":"3673_CR149","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1186\/s12885-020-07697-1","volume":"20","author":"C Tekin","year":"2020","unstructured":"Tekin C, et al. Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-\u03b1 secretion. BMC Cancer. 2020;20(1):1183.","journal-title":"BMC Cancer"},{"issue":"1","key":"3673_CR150","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/jsre.1998.5560","volume":"83","author":"TP McDade","year":"1999","unstructured":"McDade TP, et al. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells. J Surg Res. 1999;83(1):56\u201361.","journal-title":"J Surg Res"},{"issue":"8","key":"3673_CR151","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00018-023-04855-z","volume":"80","author":"AC Lilly","year":"2023","unstructured":"Lilly AC, Astsaturov I, Golemis EA. Intrapancreatic fat, pancreatitis, and pancreatic cancer. Cell Mol Life Sci. 2023;80(8):206.","journal-title":"Cell Mol Life Sci"},{"issue":"23","key":"3673_CR152","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.3390\/molecules27238630","volume":"27","author":"F Vlavcheski","year":"2022","unstructured":"Vlavcheski F, et al. Effects of berberine against pancreatitis and pancreatic cancer. Molecules. 2022;27(23):8630.","journal-title":"Molecules"},{"issue":"9988","key":"3673_CR153","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(14)60649-8","volume":"386","author":"PG Lankisch","year":"2015","unstructured":"Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015;386(9988):85\u201396.","journal-title":"Lancet"},{"issue":"10249","key":"3673_CR154","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0140-6736(20)31318-0","volume":"396","author":"G Beyer","year":"2020","unstructured":"Beyer G, et al. Chronic pancreatitis. Lancet. 2020;396(10249):499\u2013512.","journal-title":"Lancet"},{"issue":"3","key":"3673_CR155","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/cancers15030761","volume":"15","author":"G Le Cosquer","year":"2023","unstructured":"Le Cosquer G, et al. Pancreatic cancer in chronic pancreatitis: pathogenesis and diagnostic approach. Cancers (Basel). 2023;15(3):761.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3673_CR156","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/cancers14010071","volume":"14","author":"Y Saiki","year":"2021","unstructured":"Saiki Y, et al. Genetic mutations of pancreatic cancer and genetically engineered mouse models. Cancers (Basel). 2021;14(1):71.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3673_CR157","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000050651","volume":"19","author":"M Ebert","year":"2001","unstructured":"Ebert M, Schandl L, Schmid RM. Differentiation of chronic pancreatitis from pancreatic cancer: recent advances in molecular diagnosis. Dig Dis. 2001;19(1):32\u20136.","journal-title":"Dig Dis"},{"key":"3673_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107555","volume":"96","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. MIF inhibitor ISO-1 alleviates severe acute pancreatitis-associated acute kidney injury by suppressing the NLRP3 inflammasome signaling pathway. Int Immunopharmacol. 2021;96: 107555.","journal-title":"Int Immunopharmacol"},{"issue":"7\u20138","key":"3673_CR159","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10495-022-01729-w","volume":"27","author":"A Al Mamun","year":"2022","unstructured":"Al Mamun A, et al. Pyroptosis in acute pancreatitis and its therapeutic regulation. Apoptosis. 2022;27(7\u20138):465\u201381.","journal-title":"Apoptosis"},{"issue":"5","key":"3673_CR160","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1053\/j.gastro.2012.03.002","volume":"142","author":"PA P\u00e9rez-Mancera","year":"2012","unstructured":"P\u00e9rez-Mancera PA, et al. What we have learned about pancreatic cancer from mouse models. Gastroenterology. 2012;142(5):1079\u201392.","journal-title":"Gastroenterology"},{"issue":"48","key":"3673_CR161","doi-asserted-by":"publisher","first-page":"18907","DOI":"10.1073\/pnas.0810111105","volume":"105","author":"OJ De La","year":"2008","unstructured":"De La OJ, et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A. 2008;105(48):18907\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3673_CR162","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1172\/JCI45797","volume":"121","author":"E Maniati","year":"2011","unstructured":"Maniati E, et al. Crosstalk between the canonical NF-\u03baB and Notch signaling pathways inhibits Ppar\u03b3 expression and promotes pancreatic cancer progression in mice. J Clin Invest. 2011;121(12):4685\u201399.","journal-title":"J Clin Invest"},{"key":"3673_CR163","doi-asserted-by":"publisher","first-page":"153303382311648","DOI":"10.1177\/15330338231164875","volume":"22","author":"DM Ma","year":"2023","unstructured":"Ma DM, et al. Pancreatitis and pancreatic cancer risk. Technol Cancer Res Treat. 2023;22:15330338231164876.","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"3673_CR164","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.hpb.2019.08.013","volume":"22","author":"J Kirkeg\u00e5rd","year":"2020","unstructured":"Kirkeg\u00e5rd J, et al. Predictors of underlying pancreatic cancer in patients with acute pancreatitis: a Danish nationwide cohort study. HPB (Oxford). 2020;22(4):553\u201362.","journal-title":"HPB (Oxford)"},{"issue":"11","key":"3673_CR165","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/s41395-018-0255-9","volume":"113","author":"O Sadr-Azodi","year":"2018","unstructured":"Sadr-Azodi O, et al. Pancreatic cancer following acute pancreatitis: a population-based matched cohort study. Am J Gastroenterol. 2018;113(11):1711\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"04","key":"3673_CR166","first-page":"122","volume":"9","author":"M Yang","year":"2017","unstructured":"Yang M, Zhang L. Analysis of prevalence and risk factors of pancreatic cancer. Chin J Med Front. 2017;9(04):122\u20134.","journal-title":"Chin J Med Front"},{"issue":"5","key":"3673_CR167","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/ijc.32971","volume":"147","author":"T Korpela","year":"2020","unstructured":"Korpela T, et al. Association between chronic pancreatitis and pancreatic cancer: A 10-year retrospective study of endoscopically treated and surgical patients. Int J Cancer. 2020;147(5):1450\u201360.","journal-title":"Int J Cancer"},{"issue":"1","key":"3673_CR168","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5334\/aogh.2463","volume":"85","author":"X Bo","year":"2019","unstructured":"Bo X, et al. Using the risk factors of pancreatic cancer and their interactions in cancer screening: a case-control study in Shanghai China. Ann Glob Health. 2019;85(1):103. https:\/\/doi.org\/10.5334\/aogh.2463.","journal-title":"Ann Glob Health"},{"issue":"4","key":"3673_CR169","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000147","volume":"11","author":"CY Jeon","year":"2020","unstructured":"Jeon CY, et al. Identification of individuals at increased risk for pancreatic cancer in a community-based cohort of patients with suspected chronic pancreatitis. Clin Transl Gastroenterol. 2020;11(4): e00147.","journal-title":"Clin Transl Gastroenterol"},{"issue":"9","key":"3673_CR170","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s10552-009-9424-x","volume":"20","author":"PM Bracci","year":"2009","unstructured":"Bracci PM, et al. Pancreatitis and pancreatic cancer in two large pooled case-control studies. Cancer Causes Control. 2009;20(9):1723\u201331.","journal-title":"Cancer Causes Control"},{"issue":"7","key":"3673_CR171","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S1590-8658(03)00221-4","volume":"35","author":"GH Sakorafas","year":"2003","unstructured":"Sakorafas GH, Sarr MG. Pancreatic cancer after surgery for chronic pancreatitis. Dig Liver Dis. 2003;35(7):482\u20135.","journal-title":"Dig Liver Dis"},{"issue":"9","key":"3673_CR172","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ajg.2017.218","volume":"112","author":"J Kirkeg\u00e5rd","year":"2017","unstructured":"Kirkeg\u00e5rd J, Mortensen FV, Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112(9):1366\u201372.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"3673_CR173","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.7314\/APJCP.2014.15.12.5029","volume":"15","author":"GX Tong","year":"2014","unstructured":"Tong GX, et al. Association between pancreatitis and subsequent risk of pancreatic cancer: a systematic review of epidemiological studies. Asian Pac J Cancer Prev. 2014;15(12):5029\u201334.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"3673_CR174","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3748\/wjg.v23.i10.1899","volume":"23","author":"N Ertz-Archambault","year":"2017","unstructured":"Ertz-Archambault N, Keim P, Von Hoff D. Microbiome and pancreatic cancer: a comprehensive topic review of literature. World J Gastroenterol. 2017;23(10):1899\u2013908.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"3673_CR175","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/bjc.2015.465","volume":"114","author":"E Vogtmann","year":"2016","unstructured":"Vogtmann E, Goedert JJ. Epidemiologic studies of the human microbiome and cancer. Br J Cancer. 2016;114(3):237\u201342.","journal-title":"Br J Cancer"},{"issue":"10","key":"3673_CR176","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s11912-014-0406-0","volume":"16","author":"AM Sheflin","year":"2014","unstructured":"Sheflin AM, Whitney AK, Weir TL. Cancer-promoting effects of microbial dysbiosis. Curr Oncol Rep. 2014;16(10):406.","journal-title":"Curr Oncol Rep"},{"key":"3673_CR177","doi-asserted-by":"crossref","unstructured":"Structure, function and diversity of the healthy human microbiome. Nature, 2012. 486(7402): 207\u201314.","DOI":"10.1038\/nature11234"},{"issue":"3","key":"3673_CR178","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/jinfdis\/jiq061","volume":"203","author":"CL Sears","year":"2011","unstructured":"Sears CL, Pardoll DM. Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J Infect Dis. 2011;203(3):306\u201311.","journal-title":"J Infect Dis"},{"issue":"3","key":"3673_CR179","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/PPO.0000000000000045","volume":"20","author":"CP Zambirinis","year":"2014","unstructured":"Zambirinis CP, et al. Pancreatic cancer, inflammation, and microbiome. Cancer J. 2014;20(3):195\u2013202.","journal-title":"Cancer J"},{"issue":"9636","key":"3673_CR180","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","volume":"372","author":"K Fukase","year":"2008","unstructured":"Fukase K, et al. Effect of eradication of helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372(9636):392\u20137.","journal-title":"Lancet"},{"issue":"2","key":"3673_CR181","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0928-4257(00)00160-1","volume":"94","author":"F Pakodi","year":"2000","unstructured":"Pakodi F, et al. Helicobacter pylori One bacterium and a broad spectrum of human disease! An overview. J Physiol Paris. 2000;94(2):139\u201352.","journal-title":"J Physiol Paris"},{"issue":"8","key":"3673_CR182","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1097\/MPA.0000000000000414","volume":"44","author":"XZ Chen","year":"2015","unstructured":"Chen XZ, et al. Cytotoxin-associated gene a-negative strains of helicobacter pylori as a potential risk factor of pancreatic cancer: a meta-analysis based on nested case-control studies. Pancreas. 2015;44(8):1340\u20134.","journal-title":"Pancreas"},{"issue":"7","key":"3673_CR183","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s10552-015-0595-3","volume":"26","author":"A Schulte","year":"2015","unstructured":"Schulte A, et al. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis. Cancer Causes Control. 2015;26(7):1027\u201335.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"3673_CR184","first-page":"26","volume":"12","author":"G Trikudanathan","year":"2011","unstructured":"Trikudanathan G, et al. Association between Helicobacter pylori infection and pancreatic cancer a cumulative meta-analysis. J Pancreas. 2011;12(1):26\u201331.","journal-title":"J Pancreas"},{"issue":"4","key":"3673_CR185","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/gutjnl-2011-300784","volume":"61","author":"JJ Farrell","year":"2012","unstructured":"Farrell JJ, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012;61(4):582\u20138.","journal-title":"Gut"},{"issue":"4","key":"3673_CR186","first-page":"299","volume":"21","author":"CJ Whatcott","year":"2015","unstructured":"Whatcott CJ, Han H, Von Hoff DD. Orchestrating the tumor microenvironment to improve survival for patients with pancreatic cancer: normalization not destruction. Pancreas Cancer J. 2015;21(4):299\u2013306.","journal-title":"Pancreas Cancer J"},{"issue":"1","key":"3673_CR187","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ccr.2009.06.011","volume":"16","author":"DD Von Hoff","year":"2009","unstructured":"Von Hoff DD, Korn R, Mousses S. Pancreatic cancer\u2013could it be that simple? A different context of vulnerability. Cancer Cell. 2009;16(1):7\u20138.","journal-title":"Cancer Cell"},{"issue":"1","key":"3673_CR188","doi-asserted-by":"publisher","first-page":"2374596","DOI":"10.1080\/19490976.2024.2374596","volume":"16","author":"J de Castilhos","year":"2024","unstructured":"de Castilhos J, et al. Microbiome and pancreatic cancer: time to think about chemotherapy. Gut Microbes. 2024;16(1):2374596.","journal-title":"Gut Microbes"},{"key":"3673_CR189","doi-asserted-by":"publisher","first-page":"14554","DOI":"10.1038\/srep14554","volume":"5","author":"P Lehouritis","year":"2015","unstructured":"Lehouritis P, et al. Local bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep. 2015;5:14554.","journal-title":"Sci Rep"},{"issue":"6356","key":"3673_CR190","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357(6356):1156\u201360.","journal-title":"Science"},{"issue":"6","key":"3673_CR191","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccell.2019.11.004","volume":"36","author":"F McAllister","year":"2019","unstructured":"McAllister F, et al. The tumor microbiome in pancreatic cancer: bacteria and beyond. Cancer Cell. 2019;36(6):577\u20139.","journal-title":"Cancer Cell"},{"issue":"4","key":"3673_CR192","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8(4):403\u201316.","journal-title":"Cancer Discov"},{"issue":"23","key":"3673_CR193","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.3390\/jcm10235624","volume":"10","author":"J Daniluk","year":"2021","unstructured":"Daniluk J, et al. Microbiome-friend or foe of pancreatic cancer? J Clin Med. 2021;10(23):5624. https:\/\/doi.org\/10.3390\/jcm10235624.","journal-title":"J Clin Med"},{"issue":"8","key":"3673_CR194","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/carcin\/bgy073","volume":"39","author":"RM Thomas","year":"2018","unstructured":"Thomas RM, et al. Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models. Carcinogenesis. 2018;39(8):1068\u201378.","journal-title":"Carcinogenesis"},{"issue":"2","key":"3673_CR195","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10555-022-10022-w","volume":"41","author":"RE Sexton","year":"2022","unstructured":"Sexton RE, et al. Connecting the human microbiome and pancreatic cancer. Cancer Metastasis Rev. 2022;41(2):317\u201331.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"3673_CR196","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4291\/wjgp.v5.i4.380","volume":"5","author":"M Bulajic","year":"2014","unstructured":"Bulajic M, Panic N, L\u00f6hr JM. Helicobacter pylori and pancreatic diseases. World J Gastrointest Pathophysiol. 2014;5(4):380\u20133.","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"8","key":"3673_CR197","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/jso.21392","volume":"100","author":"M Ikebe","year":"2009","unstructured":"Ikebe M, et al. Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4\/MyD88 signaling pathway. J Surg Oncol. 2009;100(8):725\u201331.","journal-title":"J Surg Oncol"},{"issue":"5","key":"3673_CR198","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1023\/A:1005521007609","volume":"45","author":"MI Vaccaro","year":"2000","unstructured":"Vaccaro MI, et al. Lipopolysaccharide directly affects pancreatic acinar cells: implications on acute pancreatitis pathophysiology. Dig Dis Sci. 2000;45(5):915\u201326.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"3673_CR199","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41564-021-00928-6","volume":"6","author":"S Nayfach","year":"2021","unstructured":"Nayfach S, et al. Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome. Nat Microbiol. 2021;6(7):960\u201370.","journal-title":"Nat Microbiol"},{"issue":"28","key":"3673_CR200","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1200\/JCO.2008.17.3526","volume":"26","author":"MM Hassan","year":"2008","unstructured":"Hassan MM, et al. Association between hepatitis B virus and pancreatic cancer. J Clin Oncol. 2008;26(28):4557\u201362.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3673_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2020.101589","volume":"45","author":"A Tijeras-Raballand","year":"2021","unstructured":"Tijeras-Raballand A, et al. Microbiome and pancreatic ductal adenocarcinoma. Clin Res Hepatol Gastroenterol. 2021;45(2): 101589.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"3673_CR202","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/1055-9965.EPI-18-0542","volume":"28","author":"E Del Castillo","year":"2019","unstructured":"Del Castillo E, et al. The microbiomes of pancreatic and duodenum tissue overlap and are highly subject specific but differ between pancreatic cancer and noncancer subjects. Cancer Epidemiol Biomark Prev. 2019;28(2):370\u201383.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"3673_CR203","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178(4):795\u2013806.e12. https:\/\/doi.org\/10.1016\/j.cell.2019.07.008.","journal-title":"Cell"},{"issue":"18","key":"3673_CR204","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.3390\/cancers14184479","volume":"14","author":"K Miyabayashi","year":"2022","unstructured":"Miyabayashi K, Ijichi H, Fujishiro M. The role of the microbiome in pancreatic cancer. Cancers (Basel). 2022;14(18):4479. https:\/\/doi.org\/10.3390\/cancers14184479.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3673_CR205","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/gutjnl-2016-312580","volume":"67","author":"X Fan","year":"2018","unstructured":"Fan X, et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut. 2018;67(1):120\u20137.","journal-title":"Gut"},{"issue":"12","key":"3673_CR206","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1136\/gutjnl-2012-303006","volume":"62","author":"DS Michaud","year":"2013","unstructured":"Michaud DS, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut. 2013;62(12):1764\u201370.","journal-title":"Gut"},{"issue":"3","key":"3673_CR207","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.gtc.2019.04.008","volume":"48","author":"TM Karpi\u0144ski","year":"2019","unstructured":"Karpi\u0144ski TM. The microbiota and pancreatic cancer. Gastroenterol Clin. 2019;48(3):447\u201364.","journal-title":"Gastroenterol Clin"},{"key":"3673_CR208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1008-0","volume":"18","author":"M-Y Wei","year":"2019","unstructured":"Wei M-Y, et al. The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer. 2019;18:1\u201315.","journal-title":"Mol Cancer"},{"issue":"3","key":"3673_CR209","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/PPO.0000000000000046","volume":"20","author":"DS Michaud","year":"2014","unstructured":"Michaud DS, Izard J. Microbiota, oral microbiome, and pancreatic cancer. Cancer J. 2014;20(3):203\u20136.","journal-title":"Cancer J"},{"issue":"10","key":"3673_CR210","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.7150\/jca.37445","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang X, et al. Pancreatic cancer, gut microbiota, and therapeutic efficacy. J Cancer. 2020;11(10):2749.","journal-title":"J Cancer"},{"issue":"4","key":"3673_CR211","first-page":"399","volume":"63","author":"M Signoretti","year":"2017","unstructured":"Signoretti M, et al. Gut microbiota and pancreatic diseases. Minerva Gastroenterol Dietol. 2017;63(4):399\u2013410.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"3673_CR212","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.572492","volume":"10","author":"Q Li","year":"2020","unstructured":"Li Q, et al. Gut microbiota: its potential roles in pancreatic cancer. Front Cell Infect Microbiol. 2020;10: 572492.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7950","key":"3673_CR213","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","volume":"615","author":"J Tintelnot","year":"2023","unstructured":"Tintelnot J, et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature. 2023;615(7950):168\u201374.","journal-title":"Nature"},{"issue":"7","key":"3673_CR214","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","volume":"71","author":"E Kartal","year":"2022","unstructured":"Kartal E, et al. A faecal microbiota signature with high specificity for pancreatic cancer. Gut. 2022;71(7):1359\u201372.","journal-title":"Gut"},{"issue":"75","key":"3673_CR215","doi-asserted-by":"publisher","first-page":"eabn0704","DOI":"10.1126\/sciimmunol.abn0704","volume":"7","author":"G Mirji","year":"2022","unstructured":"Mirji G, et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Sci Immunol. 2022;7(75):eabn0704. https:\/\/doi.org\/10.1126\/sciimmunol.abn0704.","journal-title":"Sci Immunol"},{"issue":"8","key":"3673_CR216","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ccell.2022.06.011","volume":"40","author":"Y Chen","year":"2022","unstructured":"Chen Y, et al. Oncogenic collagen I homotrimers from cancer cells bind to \u03b13\u03b21 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. Cancer Cell. 2022;40(8):818-834.e9.","journal-title":"Cancer Cell"},{"issue":"9","key":"3673_CR217","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3390\/cancers12092346","volume":"12","author":"JY Jeong","year":"2020","unstructured":"Jeong JY, et al. Diversity in the extracellular vesicle-derived microbiome of tissues according to tumor progression in pancreatic cancer. Cancers (Basel). 2020;12(9):2346. https:\/\/doi.org\/10.3390\/cancers12092346.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3673_CR218","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s42003-021-02557-5","volume":"4","author":"W Guo","year":"2021","unstructured":"Guo W, et al. Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer. Commun Biol. 2021;4(1):1019.","journal-title":"Commun Biol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03673-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03673-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03673-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T15:59:54Z","timestamp":1740239994000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03673-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":218,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3673"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03673-6","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}